All In Biotech

Drug Trial Radar · NCT00061594

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

A Phase III, Multicenter, Randomized, Double Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne) Photodynamic Therapy in Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration

Last checked: Nov 20, 2026Latest source record: Mar 19, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 426 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

426

Actual

Start

May 2003

Primary completion

Not stated

Study completion Sep 2006

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
May 30, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase III, multicenter, randomized, double-masked, active treatment-controlled study of intravitreally administered ranibizumab compared with verteporfin (Visudyne) photodynamic therapy (PDT) in treating subfoveal neovascular mascular degeneration.

Conditions

  • Macular Degeneration

Interventions

  • rhuFab V2 (ranibizumab)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

82 sites in 6 countries. Site status is shown where the registry gives one.

  • Retina Centers, P.C.

    Tucson, Arizona

  • University of Arizona

    Tucson, Arizona

  • Retina-Vitreous Associates Medical Group

    Beverly Hills, California

  • UC Irvine

    Irvine, California

  • Doheny Eye Institute

    Los Angeles, California

  • California Vitreoretinal Research Center

    Menlo Park, California

  • No. California Retina-Vitreous Associates

    Mountain View, California

  • UCSF School of Medicine

    San Francisco, California

  • Danbury Eye Physicians & Surgeons

    Danbury, Connecticut

  • New England Retina Associates

    Hamden, Connecticut

  • Florida Retina Institute

    Daytona Beach, Florida

  • Retina Vitreous Consultants

    Fort Lauderdale, Florida

  • Retina Consultants of Southwest Florida

    Fort Myers, Florida

  • Retina Health Center

    Fort Myers, Florida

  • Retina Associates of South Florida

    Margate, Florida

  • Bascom Palmer Eye Institute

    Miami, Florida

  • Central Florida Retina

    Orlando, Florida

  • Retina Care Specialists

    Palm Beach Gardens, Florida

  • Bascom Palmer Eye Institute

    Palm Beach Gardens, Florida

  • Ophthalmic Consultants

    Sarasota, Florida

  • Southern Vitreoretinal Associates PA

    Tallahassee, Florida

  • University of South Florida

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • Medical College of Georgia

    Augusta, Georgia

  • Thomas A. Ciulla, MD, PC

    Indianapolis, Indiana

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Retina Associates PC

    Annapolis, Maryland

  • New England Eye Center

    Boston, Massachusetts

  • Center for Eye Research

    Boston, Massachusetts

  • New England Retina Consultants

    West Springfield, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Associated Retinal Consultants

    Grand Rapids, Michigan

  • Associated Retinal Consultants, P.C.

    Royal Oak, Michigan

  • Retina Consultants of Michigan

    Southfield, Michigan

  • Retina Associates of St. Louis

    Florissant, Missouri

  • St. Louis University Eye Institute

    St Louis, Missouri

  • Delaware Valley Retina Associates

    Lawrenceville, New Jersey

  • Lions Eye Institute

    Albany, New York

  • Ophthalmic Consultants of Long Island

    Rockville Centre, New York

  • Western Carolina Retinal Associates, PA

    Asheville, North Carolina

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.